$13.24
-0.43-3.15%
At close: -
$13.17
-0.07-0.53%
After Hours: Jan 31, 5:18 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Arcutis Biotherapeutics in recent months.
Browse guidance and forecast on all stocks.